KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Palvella Therapeutics (PVLA) Tax Provisions: 2014-2018

Historic Tax Provisions for Palvella Therapeutics (PVLA) over the last 1 years, with Dec 2018 value amounting to -$164,000.

  • Palvella Therapeutics' Tax Provisions fell 213.89% to -$164,000 in Q4 2018 from the same period last year, while for Dec 2018 it was -$22,000, marking a year-over-year decrease of 101.74%. This contributed to the annual value of $164,000 for FY2020, which is N/A change from last year.
  • As of Q4 2018, Palvella Therapeutics' Tax Provisions stood at -$164,000, which was down 10.81% from -$148,000 recorded in Q2 2018.
  • In the past 5 years, Palvella Therapeutics' Tax Provisions registered a high of $814,000 during Q2 2017, and its lowest value of -$164,000 during Q4 2018.
  • For the 2-year period, Palvella Therapeutics' Tax Provisions averaged around $158,400, with its median value being $144,000 (2017).
  • Data for Palvella Therapeutics' Tax Provisions shows a maximum YoY plummeted of 213.89% (in 2018) over the last 5 years.
  • Quarterly analysis of 4 years shows Palvella Therapeutics' Tax Provisions stood at -$18 in 2014, then reached $163,425 in 2015, then reached $144,000 in 2017, then crashed by 213.89% to -$164,000 in 2018.
  • Its Tax Provisions stands at -$164,000 for Q4 2018, versus -$148,000 for Q2 2018 and $144,000 for Q4 2017.